Uterine (Endometrial) Cancer

This information is useful for adults and older adults
uterine cancer
Why Yale Medicine?
  • Our researchers are leaders in the field of uterine cancer research.
  • We offer the latest methods of care, from minimally invasive surgery to personalized therapies.
  • We have extensive experience treating rare forms of uterine cancer, including clinical trials.

While a diagnosis of uterine cancer can be scary, it is important to know that its most common form—endometrial cancer—is highly curable. Uterine cancer is a blanket term for a group of cancers that can develop inside a woman’s uterus. Because endometrial cancer occurs the most frequently, with an estimated 60,000 new cases expected in 2016, it is commonly referred to as uterine cancer. It is caused by mutations in the cells that form in the lining (endometrium) of the uterus.

"One in 35 women roughly will develop endometrial cancer, but it is often caught early and it responds well to treatment," says Yale Medicine's Gloria Huang, MD, a gynecologic oncologist. "Once patients are treated, which is usually done very successfully, they worry about uterine cancer returning, but the risk of dying from an obesity-related problem, such as heart disease, is, in fact, much higher for many women."  

At Yale Medicine, our team of researchers, including physicians such as Dr. Huang are leaders in the development of innovative treatments for women with uterine and other cancers of the reproductive tract. Our physicians are also skilled in the most up-to-date, minimally invasive forms of surgery.

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.